No definition available.
Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls
KRA_PSY_PUERPER_EXMORE
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleonly females |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- KRA_PSY_ANYMENTAL
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F50-F59
- Name in latin
- Perturbationes mentis et modi se gerendi puerperio adjunctae non alibi classificatae
Similar endpoints
↥List of similar endpoints to
Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls
based on the number of shared cases.
Similar with more cases:
- Mental and behavioural disorders of puerperium, not classified elsewhere
- Mental and behavioural disorders associated with the puerperium
- Behavioural syndromes associated with physiological disturbances and physical factors
- Any mental disorder
- Psychiatric diseases
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2607 | 2607 | - |
| Only index persons | 2525 | 2525 | - |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.07 | 0.07 | - |
| Only index persons | 0.09 | 0.09 | - |
| Median age at first event (years) | |||
| Whole population | - | 29.39 | - |
| Only index persons | - | 29.37 | - |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 425 | 425 | - |
| Unadjusted period prevalence (%) | 0.14 | 0.14 | - |
| Median age at first event (years) | 30.32 | 30.32 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 388
- Matched controls
- 3880
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F53.0
ICD-10 Finland
Mild mental and behavioural disorders associated with the puerperium, not elsewhere classified
2852.0
186.1
165
*
N05AH04
ATC
quetiapine; oral
41.0
152.4
196
94
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
488.1
138.2
130
*
F53.1
ICD-10 Finland
Severe mental and behavioural disorders associated with the puerperium, not elsewhere classified
+∞
123.7
112
*
N05AH03
ATC
olanzapine; systemic
701.6
110.7
104
*
N05BA04
ATC
oxazepam; oral
12.4
95.6
205
322
F32.9
ICD-10 Finland
Depressive episode, unspecified
23.3
88.5
132
84
29440
ICD-8 Finland
Psychosis associated with other physical conditions, Childbirth
+∞
80.0
74
*
F29
ICD-10 Finland
Unspecified nonorganic psychosis
893.2
77.1
73
*
N05AX08
ATC
risperidone; systemic
128.0
69.6
73
7
F53.9
ICD-10 Finland
Puerperal mental disorder, unspecified
+∞
65.5
61
*
N06AB06
ATC
sertraline; oral
15.8
65.2
112
97
N05AX12
ATC
aripiprazole; systemic
254.5
64.3
64
*
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
68.3
59.9
68
12
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
31.7
57.9
77
30
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
74.8
56.3
63
10
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
28.7
54.9
75
32
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
12.4
52.9
101
107
N06AB04
ATC
citalopram; systemic
7.8
52.6
139
260
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
14.4
52.6
93
83
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
555.8
50.6
49
*
N03AG01
ATC
valproic acid; systemic, rectal
23.6
49.8
72
37
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
87.1
48.3
53
7
N05AB03
ATC
perphenazine; systemic, rectal
97.6
47.1
51
6
N05AA02
ATC
levomepromazine; systemic
504.1
46.3
45
*
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
66.4
45.7
52
9
N05AN01
ATC
lithium; oral
491.4
45.2
44
*
N06AX11
ATC
mirtazapine; oral
5.5
45.2
165
457
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
+∞
43.6
41
*
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
+∞
41.4
39
*
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
228.5
40.7
41
*
N06AX16
ATC
venlafaxine; oral
8.0
40.6
100
161
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
+∞
38.2
36
*
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
392.0
36.6
36
*
N05CD07
ATC
temazepam; oral
14.8
36.3
62
49
N05BA06
ATC
lorazepam; systemic, sublingual
41.1
35.5
44
12
P76
ICPC
Depressive disorder
12.6
34.7
64
60
N06AB03
ATC
fluoxetine; oral
7.9
33.4
81
125
N05CF01
ATC
zopiclone; oral
4.6
32.5
136
409
N05AF03
ATC
chlorprothixene; systemic
+∞
31.7
30
*
N03AX09
ATC
lamotrigine; oral
18.5
31.6
49
30
N05AA01
ATC
chlorpromazine; systemic, rectal
+∞
30.6
29
*
T36
ICD-10 Finland
Poisoning by systemic antibiotics
49.4
30.2
36
8
N05AD01
ATC
haloperidol; systemic
115.9
30.1
32
*
IGY02
NOMESCO Finland
Psychiatric monitoring contact
+∞
29.6
28
*
ZY010
NOMESCO Finland
Hospital outpatient
20.5
29.5
44
24
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
314.3
29.2
29
*
N06AB10
ATC
escitalopram; oral
4.4
28.9
123
370
P01
ICPC
Feeling anxious/nervous/tense
5.7
28.6
90
195
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
+∞
27.4
26
*
ZY000
NOMESCO Finland
Hospital inpatient
+∞
26.3
25
*
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
278.1
26.0
26
*
Z2446
NOMESCO Finland
Social worker
12.0
25.9
48
45
N04AA02
ATC
biperiden; systemic
138.9
24.9
26
*
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
6.5
24.9
68
122
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
+∞
24.2
23
*
N06AX12
ATC
bupropion; oral
10.0
24.1
49
55
N06AB05
ATC
paroxetine; oral
9.9
23.9
49
56
O99.80
ICD-10 Finland
The fear of childbirth
5.3
23.6
78
177
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
+∞
23.2
22
*
F31.8
ICD-10 Finland
Other bipolar affective disorders
69.4
23.1
26
*
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
243.8
22.9
23
*
N05AC02
ATC
thioridazine; oral
29.4
22.6
30
11
P29
ICPC
Psychological sympt/compl other
7.8
22.4
53
77
F20.9
ICD-10 Finland
Schizophrenia, unspecified
+∞
22.1
21
*
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
+∞
22.1
21
*
SPAT1240
SPAT
Therapeutic discussion
4.7
22.1
82
210
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
232.6
21.8
22
*
P99
ICPC
Psychological disorders other
26.0
21.2
29
12
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
+∞
21.0
20
*
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
+∞
21.0
20
*
F41.1
ICD-10 Finland
Generalized anxiety disorder
10.5
20.9
41
43
IGY99
NOMESCO Finland
Other psychiatric treatment contact
221.4
20.8
21
*
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
17.6
20.0
31
19
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
+∞
18.9
18
*
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
+∞
18.9
18
*
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
73.7
18.9
21
*
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
105.2
18.7
20
*
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
31.8
18.6
24
8
N06AA12
ATC
doxepin; systemic
17.6
18.1
28
17
F53.8
ICD-10 Finland
Other mental and behavioural disorders associated with the puerperium, not elsewhere classified
+∞
17.8
17
*
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
+∞
17.8
17
*
ZYC01
NOMESCO Finland
Remote contact by phone
12.9
17.6
31
26
F51.0
ICD-10 Finland
Nonorganic insomnia
3.9
17.3
78
237
P74
ICPC
Anxiety disorder/anxiety state
9.5
17.1
35
40
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
+∞
16.8
16
*
F60.9
ICD-10 Finland
Personality disorder, unspecified
+∞
16.8
16
*
P72
ICPC
Schizophrenia
177.3
16.6
17
*
Z2445
NOMESCO Finland
Psychologist
15.2
16.6
27
19
F34.1
ICD-10 Finland
Dysthymia
22.1
16.2
23
11
N05BA12
ATC
alprazolam; oral
5.2
16.1
52
113
P03
ICPC
Feeling depressed
4.5
15.8
59
150
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
+∞
15.7
15
*
N05BA01
ATC
diazepam; systemic, rectal
4.9
15.7
53
121
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
8.2
15.3
34
45
N06AX03
ATC
mianserin; oral
13.2
15.1
26
21
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
3.0
15.1
102
417
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
7.1
14.7
36
55
188
Kela drug reimbursment
Psychosis requiring demanding treatment
+∞
14.7
14
*
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
+∞
14.7
14
*
N05AH02
ATC
clozapine; systemic
+∞
14.7
14
*
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
+∞
14.7
14
*
F32
ICD-10 Finland
Depressive episode
7.0
14.5
36
56
P06
ICPC
Sleep disturbance
4.2
14.5
57
152
F99
ICD-10 Finland
Mental disorder, not otherwise specified
55.4
13.9
16
*
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
6.9
13.7
34
53
N05AF05
ATC
zuclopenthixol; systemic
+∞
13.6
13
*
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
+∞
13.6
13
*
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
+∞
13.6
13
*
N06AX21
ATC
duloxetine; oral
4.2
13.3
52
138
N05BE01
ATC
buspirone; oral
19.9
13.0
19
10
N05CF02
ATC
zolpidem; oral
3.0
12.9
81
313
F31
ICD-10 Finland
Bipolar affective disorder
72.3
12.7
14
*
2988A
ICD-9 Finland
Other nonorganic psychoses, Other and unspecified reactive psychosis
+∞
12.6
12
*
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
+∞
12.6
12
*
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
+∞
12.6
12
*
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
134.2
12.5
13
*
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
15.0
12.4
20
14
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
7.3
11.9
28
41
F31.31
ICD-10 Finland
Bipolar disorder depressive episode with somatic syndrome
+∞
11.5
11
*
P98
ICPC
Psychosis NOS/other
+∞
11.5
11
*
29999
ICD-8 Finland
Unspecified psychosis
+∞
11.5
11
*
IEY01
NOMESCO Finland
Psychoeducation, individual
+∞
11.5
11
*
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
+∞
11.5
11
*
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
+∞
11.5
11
*
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
2.1
11.3
206
1359
N06CA01
ATC
amitriptyline and psycholeptics; systemic
4.1
11.1
44
118
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
44.7
11.0
13
*
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
8.4
10.8
23
29
F32.1
ICD-10 Finland
Moderate depressive episode
5.7
10.7
30
56
F41.09
ICD-10 Finland
UNS Panic Syndrome
14.7
10.6
17
12
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
5.8
10.5
29
53
IDY03
NOMESCO Finland
Systematic individual therapy, cognitive-behavioural
113.0
10.5
11
*
F33.3
ICD-10 Finland
Recurrent depressive disorder, current episode severe with psychotic symptoms
+∞
10.5
10
*
AA400
NOMESCO Finland
Electroconvulsive therapy
+∞
10.5
10
*
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
+∞
10.5
10
*
F39
ICD-10 Finland
Unspecified mood [affective] disorder
+∞
10.5
10
*
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
+∞
10.5
10
*
N05AE04
ATC
ziprasidone; systemic
+∞
10.5
10
*
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
33.5
10.4
13
*
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
2.1
10.4
147
862
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
19.4
10.3
15
8
N06AX22
ATC
agomelatine; oral
24.1
10.3
14
6
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
5.3
10.3
31
63
A06AD11
ATC
lactulose; oral
4.1
10.3
40
106
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
5.6
10.2
29
55
N06AX05
ATC
trazodone; oral
15.1
10.1
16
11
R3110
NOMESCO Finland
Psychosocial training
6.6
10.0
25
40
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
11.0
9.9
18
17
N06AX26
ATC
vortioxetine; oral
5.6
9.9
28
53
F41.8
ICD-10 Finland
Other specified anxiety disorders
8.2
9.7
21
27
T90
ICPC
Diabetes non-insulin dependent
3.0
9.6
56
204
F41.00
ICD-10 Finland
Moderate panic disorder
102.4
9.5
10
*
N06AX18
ATC
reboxetine; oral
102.4
9.5
10
*
P73
ICPC
Affective psychosis
+∞
9.4
9
*
F10.09
ICD-10 Finland
Alcohol intoxication UNS
+∞
9.4
9
*
F28
ICD-10 Finland
Other nonorganic psychotic disorders
+∞
9.4
9
*
F20.04
ICD-10 Finland
Paranoid schizophrenia with partial recurrence
+∞
9.4
9
*
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
+∞
9.4
9
*
F42.0
ICD-10 Finland
Predominantly obsessional thoughts or ruminations
+∞
9.4
9
*
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
+∞
9.4
9
*
N07BB01
ATC
disulfiram; oral
22.3
9.4
13
6
SPAT1389
SPAT
Visit based on need for special support
6.3
9.4
24
40
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
9.2
157
983
AA1AD
NOMESCO Finland
CT of head and brain
2.8
9.2
60
235
N05AL01
ATC
sulpiride; systemic
37.6
9.1
11
*
N06AB08
ATC
fluvoxamine; oral
9.8
8.9
17
18
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
2.4
8.8
82
391
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
6.9
8.8
21
32
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
28.2
8.5
11
*
C07AA05
ATC
propranolol; systemic
2.3
8.5
84
413
IGP01
NOMESCO Finland
Psychiatric family contact
92.0
8.4
9
*
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
13.1
8.4
14
11
F23.3
ICD-10 Finland
Other acute predominantly delusional psychotic disorders
+∞
8.4
8
*
F23.99
ICD-10 Finland
Acute and transient psychosis, unspecified UNS
+∞
8.4
8
*
F31.21
ICD-10 Finland
Bipolar disorder, manic episode with mood incongruent psychotic symptoms
+∞
8.4
8
*
2954A
ICD-9 Finland
Schizophrenic psychoses, Acute schizophrenic episode
+∞
8.4
8
*
ZXY83
NOMESCO Finland
Social worker in multidisciplinary team
+∞
8.4
8
*
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
+∞
8.4
8
*
F40.01
ICD-10 Finland
Agoraphobia with concomitant panic disorder
+∞
8.4
8
*
P28
ICPC
Limited function/disability (P)
+∞
8.4
8
*
ZXY49
NOMESCO Finland
Other health care provider
+∞
8.4
8
*
IGV01
NOMESCO Finland
Psychiatric network contact
+∞
8.4
8
*
N06AA22
ATC
NA
+∞
8.4
8
*
SPAT1241
SPAT
Extensive assessment of psychosocial situation
12.1
8.1
14
12
Z3231
NOMESCO Finland
Registered nurse
2.2
8.1
88
450
A10BA02
ATC
metformin; oral
2.5
8.1
66
294
F40.1
ICD-10 Finland
Social phobias
22.6
8.1
11
5
F43.29
ICD-10 Finland
Adaptation disorder UNS
9.7
7.8
15
16
SPAT1254
SPAT
Administration of medicine
2.8
7.8
49
188
SPAT1234
SPAT
Support of social functional capacity
8.3
7.7
16
20
N05AF01
ATC
flupentixol; systemic
25.6
7.6
10
*
SPAT1307
SPAT
Psychosocial counselling and guidance
3.5
7.5
34
104
N06AG02
ATC
moclobemide; oral
7.9
7.5
16
21
F23.8
ICD-10 Finland
Other acute and transient psychotic disorders
+∞
7.3
7
*
29580
ICD-8 Finland
Schizophrenia, Other
+∞
7.3
7
*
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
+∞
7.3
7
*
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
+∞
7.3
7
*
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
+∞
7.3
7
*
F23.90
ICD-10 Finland
Acute and transient psychosis, unspecified without acute stress factor
+∞
7.3
7
*
2957A
ICD-9 Finland
Schizophrenic psychoses, Schizo-affective type
+∞
7.3
7
*
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
+∞
7.3
7
*
30040
ICD-8 Finland
Neuroses, Neurotico-depressiva
+∞
7.3
7
*
F21
ICD-10 Finland
Schizotypal disorder
+∞
7.3
7
*
G02CB01
ATC
bromocriptine; systemic
5.0
7.3
22
46
SPAT1222
SPAT
Counselling/guidance promoting independent living
3.0
7.3
42
153
N06AA09
ATC
amitriptyline; systemic
3.6
7.2
31
91
O80.0
ICD-10 Finland
Spontaneous vertex delivery
1.8
7.0
211
1563
F43.9
ICD-10 Finland
Reaction to severe stress, unspecified
7.8
7.0
15
20
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
6.9
119
731
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
2.1
6.8
79
414
H03AA01
ATC
levothyroxine sodium; systemic
2.0
6.7
100
580
Z73.9
ICD-10 Finland
Problem related to life-management difficulty, unspecified
23.0
6.7
9
*
Z73.8
ICD-10 Finland
Other problems related to life-management difficulty
23.0
6.7
9
*
SPAT1262
SPAT
Handing over of treatment supplies
2.6
6.7
47
194
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.9
6.7
117
724
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
1.8
6.6
138
904
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
6.6
128
816
A98
ICD-10 Finland
Other viral haemorrhagic fevers, not elsewhere classified
7.0
6.6
15
22
N03AE01
ATC
clonazepam; systemic
6.4
6.5
16
26
L17
ICPC
Foot/toe symptom/complaint
2.0
6.5
85
469
IBA03
NOMESCO Finland
Psychotherapy evaluation
71.0
6.4
7
*
F50.9
ICD-10 Finland
Eating disorder, unspecified
71.0
6.4
7
*
SPAT1310
SPAT
Counselling related to known health issue
1.9
6.4
116
723
XF400
NOMESCO Finland
ECG with 12 standard connections
2.9
6.3
37
136
R53
ICD-10 Finland
Malaise and fatigue
2.1
6.3
76
405
ZXD05
NOMESCO Finland
Urgent procedure
1.8
6.3
139
922
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
+∞
6.3
6
*
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
+∞
6.3
6
*
IBC98
NOMESCO Finland
Other child protection assessment
+∞
6.3
6
*
F20.34
ICD-10 Finland
Undifferentiated schizophrenia with partial recurrence
+∞
6.3
6
*
F22.0
ICD-10 Finland
Delusional disorder
+∞
6.3
6
*
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
+∞
6.3
6
*
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
+∞
6.3
6
*
ZYD01
NOMESCO Finland
Emergency clinic
+∞
6.3
6
*
F20.0
ICD-10 Finland
Paranoid schizophrenia
+∞
6.3
6
*
IER01
NOMESCO Finland
Psychoeducation, group
+∞
6.3
6
*
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
+∞
6.3
6
*
F30.1
ICD-10 Finland
Mania without psychotic symptoms
+∞
6.3
6
*
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
+∞
6.3
6
*
N05AH05
ATC
asenapine; oral
+∞
6.3
6
*
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
+∞
6.3
6
*
F60.8
ICD-10 Finland
Other specific personality disorders
+∞
6.3
6
*
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
+∞
6.3
6
*
N05AD03
ATC
melperone; systemic
+∞
6.3
6
*
W78
ICPC
Pregnancy
1.8
6.2
132
867
F43.1
ICD-10 Finland
Post-traumatic stress disorder
7.9
6.2
13
17
MCA10
NOMESCO Finland
Lower uterine segment caesarean section
2.0
6.1
89
511
K59.09
ICD-10 Finland
Constipation, unspecified
5.0
6.1
18
37
Z34.9
ICD-10 Finland
Supervision of normal pregnancy, unspecified
1.9
6.1
97
576
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
2.0
6.0
81
450
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
106
260
5.10
41.87
1.8
1.3
%
1.4
1.2
5.22
96
237
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
35
0
+∞
37.02
14.8
0.0
mmol/l
0.7
—
—
29
0
(3028707) Methadone [Presence] in Urine by Screen method
31
19
17.52
36.99
2.7
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
171
812
2.85
23.39
2.5
3.1
mmol/l
2.3
2.4
0.69
158
733
(3019309) Folate [Moles/volume] in Red Blood Cells
82
264
3.61
21.63
1.7
1.5
nmol/l
1271.3
1198.5
0.24
67
213
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
204
1094
2.66
21.58
5.1
4.4
mmol/l
1.2
1.2
0.16
170
931
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
319
2216
2.76
18.61
6.0
5.8
u/l
69.6
70.6
0.26
309
2077
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
112
492
2.73
17.04
1.8
1.5
pmol/l
434.0
33787275.1
0.80
101
441
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
173
944
2.40
16.59
4.9
3.7
mmol/l
1.2
1.2
0.08
157
861
(3021960) Folate [Moles/volume] in Serum or Plasma
105
461
2.70
15.88
1.6
1.3
nmol/l
20.6
22.4
0.58
95
411
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
163
885
2.37
15.62
1.8
1.6
pmol/l
99.3
101.0
0.19
94
456
(3011288) Drugs identified in Urine by Screen method
36
81
4.76
15.25
3.8
1.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
235
1547
2.16
13.51
4.4
3.1
mmol/l
6.3
6.2
0.38
210
1356
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
173
1016
2.19
13.28
2.9
2.8
u/l
28.6
26.8
0.39
164
975
(3018418) pH of Serum or Plasma
118
629
2.21
11.24
4.1
3.3
ph
7.4
7.4
0.19
24
116
(1001926) Buprenorphine [Presence] in Urine by Screen method
37
108
3.66
11.11
2.6
1.1
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
14
5
28.86
10.79
3.5
2.8
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
10
0
+∞
10.46
8.4
0.0
nmol/l
1518.1
—
—
10
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
10
0
+∞
10.46
7.2
0.0
nmol/l
830.1
—
—
10
0
(3026008) Bacteria identified in Urine by Culture
147
874
2.04
10.42
3.0
2.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
161
1002
1.98
9.94
1.8
1.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
308
2390
2.05
9.83
3.3
2.2
u/l
32.0
29.9
0.34
295
2296
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
378
3185
2.69
9.82
4.4
3.1
mmol/l
5.7
5.5
1.58
355
2995
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
195
1303
1.92
9.69
2.2
2.1
nmol/l
72.7
76.2
1.15
182
1219
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
136
804
2.02
9.67
3.2
2.1
u/l
53.6
55.6
0.30
121
744
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
356
2932
2.32
9.53
6.2
4.0
pmol/l
14.0
14.3
1.98
342
2769
(3000764) Benzodiazepines [Presence] in Urine
44
158
2.99
9.50
2.5
1.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
157
982
1.95
9.46
4.3
3.8
g/l
36.1
37.2
1.74
147
914
(3019550) Sodium [Moles/volume] in Serum or Plasma
386
3305
2.83
9.34
12.5
7.2
mmol/l
139.3
139.6
2.14
381
3200
(3002032) Base excess in Venous blood by calculation
35
111
3.35
9.27
2.3
2.8
mmol/l
0.9
1.9
0.61
25
84
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
136
819
1.97
9.09
2.7
2.2
ng/l
20.7
17.0
0.18
59
319
(3028300) Cannabinoids [Presence] in Urine
44
162
2.91
9.09
2.5
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
386
3317
2.78
9.04
12.9
7.3
mmol/l
3.9
3.9
0.37
379
3202
(3016879) Cocaine [Presence] in Urine
40
140
3.05
9.02
2.5
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
93
490
2.15
8.93
4.0
2.9
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
43
161
2.86
8.61
2.3
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
88
463
2.14
8.45
2.9
2.1
mosm/kgh2o
519.8
525.4
0.06
76
396
(3031040) Bacteria [#/volume] in Urine by Automated count
292
2286
1.89
8.29
5.3
3.4
e6/l
7021.0
648.8
—
5
25
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
78
396
2.19
8.18
2.3
2.1
u/l
5970.4
5514.9
0.05
35
189
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
199
1393
1.81
8.11
4.6
4.8
umol/l
9.0
9.8
0.94
189
1300
(3019225) pH of Specimen
48
198
2.61
7.99
3.2
2.5
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
217
1564
1.79
7.97
6.1
5.0
e9/l
0.0
0.0
0.21
188
1400
(42870588) Differential panel, method unspecified - Blood
145
926
1.86
7.94
5.4
5.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
216
1557
1.79
7.91
6.0
5.0
e9/l
0.5
0.5
0.57
187
1396
(3044889) 12 lead EKG panel
256
1947
1.79
7.74
3.1
2.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
116
696
1.92
7.66
1.7
1.9
mg/l
2.8
2.6
0.47
96
598
(3013650) Neutrophils [#/volume] in Blood by Automated count
242
1819
1.77
7.54
9.7
6.9
e9/l
4.2
3.9
1.60
215
1597
(3013115) Eosinophils [#/volume] in Blood
223
1640
1.76
7.47
6.4
4.9
e9/l
0.2
0.2
0.03
199
1483
(3036481) Cortisol [Moles/volume] in Serum or Plasma
59
278
2.30
7.37
1.4
2.0
nmol/l
380.4
374.3
0.08
51
258
(3013707) Erythrocyte sedimentation rate by Westergren method
302
2431
1.84
7.36
3.6
3.5
mm/h
10.6
8.8
2.20
288
2280
(3019069) Monocytes/100 leukocytes in Blood
203
1463
1.74
7.23
5.7
5.2
%
7.8
7.9
0.29
194
1387
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
386
3400
2.47
7.07
7.2
4.5
mu/l
1.6
2.1
0.84
371
3232
(3015736) pH of Urine
181
1269
1.74
7.07
4.0
2.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
40
161
2.64
6.99
2.4
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
55
258
2.30
6.94
3.5
3.7
pmol/l
4.5
4.7
0.45
46
236
(3019198) Lymphocytes [#/volume] in Blood
220
1637
1.71
6.86
6.3
4.9
e9/l
2.1
2.0
0.94
195
1493
(3006504) Eosinophils/100 leukocytes in Blood
200
1453
1.71
6.79
5.5
5.0
%
2.6
2.8
0.43
189
1368
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
137
897
1.78
6.72
3.8
2.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
71
374
2.08
6.72
1.9
2.2
mmol/l
2.4
2.4
0.40
63
319
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
25
79
3.30
6.68
1.8
1.9
mmol/l
2.3
0.5
0.73
15
52
(3019150) Specific gravity of Urine by Refractometry
108
659
1.86
6.67
5.3
3.4
kg/l
1.0
1.0
0.36
16
103
(40758558) Short blood count panel - Blood
115
717
1.83
6.63
5.6
5.2
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
206
1525
1.68
6.40
5.8
4.8
%
56.6
56.6
0.02
194
1445
(3012095) Magnesium [Moles/volume] in Serum or Plasma
62
318
2.11
6.28
3.4
3.1
mmol/l
0.8
0.8
3.65
57
301
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
396
3564
2.63
6.28
12.5
8.2
mg/l
19.2
18.9
0.07
319
2643
(3002030) Lymphocytes/100 leukocytes in Blood
207
1543
1.67
6.21
5.4
4.9
%
30.1
29.6
0.25
196
1459
(3003458) Phosphate [Moles/volume] in Serum or Plasma
45
203
2.36
6.20
6.2
4.4
mmol/l
1.1
1.0
0.45
40
189
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
25
84
3.10
6.06
1.8
1.9
kpa
5.0
4.9
0.20
25
79
(3022096) Basophils/100 leukocytes in Blood
191
1401
1.66
6.05
5.6
5.1
%
0.6
0.7
0.74
181
1316
(3015235) Bicarbonate [Moles/volume] in Capillary blood
14
31
4.64
6.02
2.1
2.0
mmol/l
22.5
24.2
0.49
14
26
(3037467) Urinalysis macro (dipstick) panel - Urine
292
2394
1.70
5.95
4.9
3.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
30
114
2.76
5.87
1.7
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
87
516
1.86
5.82
3.0
2.0
e6/l
8.0
9.9
0.46
75
452
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
114
737
1.75
5.72
1.8
1.7
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
117
764
1.73
5.66
3.3
2.4
e6/l
14.0
86.3
1.19
96
559
(3018095) Leukocytes [#/volume] in Urine
146
1013
1.67
5.65
3.7
2.7
e6/l
24.5
63.1
1.46
99
630
(3009508) Creatinine [Moles/volume] in Urine
101
633
1.78
5.63
3.8
3.1
mmol/l
6.3
7.7
2.36
84
544
(3011397) Hemoglobin [Presence] in Urine by Test strip
109
700
1.75
5.59
4.3
2.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
220
1700
1.61
5.48
4.8
3.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
220
1700
1.61
5.48
4.6
2.9
estimate
0.0
0.0
0.00
46
347
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
37
163
2.39
5.39
5.9
3.0
mmol/l
1.2
1.2
1.20
28
138
(3000991) Gas panel - Venous blood
26
97
2.79
5.27
5.8
6.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
37
165
2.36
5.25
1.9
2.1
g/l
0.2
0.2
0.31
32
160
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
49
246
2.12
5.24
2.5
2.0
u/l
36.7
34.7
0.09
44
210
(3001122) Ferritin [Mass/volume] in Serum or Plasma
245
1959
1.59
5.16
3.2
2.7
ug/l
63.6
59.4
0.24
232
1871
(3021589) Normoblasts [#/volume] in Blood
192
1451
1.59
5.15
8.7
6.7
e9/l
0.0
0.0
0.54
153
1219
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
96
613
1.73
4.97
1.8
1.9
u/l
240.5
223.4
0.04
91
584
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
402
3713
2.53
4.76
10.0
7.3
u/l
22.4
23.2
0.62
396
3598
(3007853) Bacteria identified in Skin by Aerobe culture
56
308
1.94
4.68
1.9
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
84
525
1.75
4.68
1.7
1.5
—
—
—
0
0
(3013512) EKG study
95
620
1.69
4.52
3.1
2.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
216
1713
1.53
4.47
5.5
4.1
estimate
0.0
0.0
0.00
49
357
(3009261) Glucose [Presence] in Urine by Test strip
218
1733
1.53
4.46
4.5
3.0
estimate
0.0
0.0
0.50
48
353
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
17
55
3.18
4.41
3.3
2.3
%
54.0
48.6
0.31
17
55
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
326
2840
1.63
4.38
5.4
3.8
mmol/mol
37.5
37.4
0.14
309
2703
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
374
3386
1.87
4.31
3.9
3.3
mmol/l
4.8
4.8
0.09
348
3237
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
373
3381
1.84
4.19
3.8
3.2
mmol/l
1.5
1.6
6.20
349
3225
(3029937) Albumin [Presence] in Urine by Test strip
127
911
1.56
4.08
5.3
3.2
estimate
0.0
0.0
0.50
46
359
(3022948) Iron [Moles/volume] in Serum or Plasma
62
369
1.80
4.06
2.8
1.9
umol/l
14.1
15.2
0.49
57
339
(3030467) Casts [#/volume] in Urine by Automated count
101
689
1.61
4.01
3.4
2.2
e6/l
0.2
0.3
0.32
83
495
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
68
418
1.75
3.99
1.9
2.5
ng/l
605.2
483.4
0.21
51
341
(3019832) Treponema pallidum Ab [Presence] in Serum
130
944
1.54
3.93
1.8
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
37
187
2.07
3.92
1.4
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
20
77
2.68
3.86
1.2
1.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
49
276
1.88
3.82
3.0
2.0
%
21.5
24.5
0.69
42
226
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
37
189
2.05
3.81
1.4
1.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
55
322
1.81
3.80
2.9
1.9
g/l
2.7
2.5
0.83
46
295
(46235355) HIV 1 and 2 tests - Meaningful Use set
164
1261
1.49
3.76
2.4
1.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
101
700
1.58
3.73
3.3
2.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
147
1107
1.50
3.72
1.9
1.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
374
3421
1.78
3.68
4.2
3.5
mmol/l
2.9
2.9
0.10
346
3246
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
357
3232
1.65
3.57
3.5
3.0
mmol/l
1.3
1.1
5.20
333
3080
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
126
926
1.51
3.56
2.7
2.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
129
953
1.51
3.56
1.4
1.2
u/ml
0.6
1.1
1.65
47
288
(3026389) Candida sp identified in Specimen by Organism specific culture
13
41
3.24
3.52
1.2
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
36
3.40
3.50
1.1
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
16
58
2.83
3.46
1.8
2.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
31
154
2.09
3.45
2.6
3.2
ng/l
70.0
63.8
0.22
26
144
(3000494) Fungus identified in Specimen by Culture
52
309
1.78
3.43
1.5
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
46
264
1.83
3.40
8.2
4.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
353
3198
1.61
3.39
9.8
6.7
ml/min/173m2
93.7
92.7
0.42
287
2537
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
86
588
1.58
3.35
2.4
2.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
169
1332
1.45
3.32
1.8
1.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
53
321
1.74
3.28
1.5
1.5
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
20
84
2.45
3.28
3.6
4.2
mmol/l
23.8
24.2
0.25
20
84
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
25
117
2.21
3.23
1.6
1.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
8
15
5.41
3.20
1.4
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
171
1366
1.42
3.07
4.7
3.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
28
141
2.06
3.03
4.7
5.3
mmol/l
0.4
0.6
0.08
22
103
(3014007) Fractional oxyhemoglobin in Arterial blood
18
75
2.46
3.01
5.4
6.6
%
94.9
95.6
0.58
18
75
(3032080) INR in Blood by Coagulation assay
109
804
1.48
2.97
5.2
4.2
inr
1.0
1.0
1.70
33
293
(3034274) Bile acid [Moles/volume] in Serum --fasting
24
116
2.13
2.89
1.4
2.3
umol/l
4.4
5.2
0.48
19
83
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
110
820
1.46
2.83
2.7
1.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
38
625
0.57
2.82
1.3
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
34
189
1.87
2.80
2.6
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
105
781
1.46
2.73
1.4
1.3
g/l
2.2
2.0
0.92
67
507
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
26
134
2.00
2.66
1.3
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
12
44
2.78
2.56
1.1
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
10
33
3.08
2.54
2.9
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
41
250
1.71
2.51
1.1
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
17
76
2.29
2.47
1.7
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
8
21
3.86
2.47
1.9
1.9
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
31
175
1.83
2.45
2.7
2.7
%
1.6
1.7
0.34
24
158
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
26
140
1.91
2.38
4.9
5.2
kpa
5.3
4.9
1.10
26
134
(3027801) Oxygen [Partial pressure] in Arterial blood
26
140
1.91
2.38
4.9
5.2
kpa
12.4
13.9
1.20
26
134
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
38
231
1.71
2.36
3.0
2.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
42
263
1.66
2.34
1.4
1.6
mu/l
476.2
278.0
1.08
37
229
(3020682) Albumin/Creatinine [Ratio] in Urine
80
583
1.46
2.30
5.2
4.1
mg/mmol
17.3
9.0
0.28
49
361
(3023323) Follitropin [Units/volume] in Serum or Plasma
60
412
1.53
2.29
1.3
1.3
iu/l
25.1
25.9
0.06
52
362
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
47
305
1.61
2.29
2.0
2.0
umol/l
4.7
5.0
0.17
38
269
(3024928) Oxygen saturation in Venous blood
8
23
3.52
2.28
1.5
2.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
113
880
1.39
2.24
4.8
3.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
29
3.15
2.23
1.1
1.3
—
—
—
0
0
(3020891) Body temperature
11
42
2.66
2.20
5.8
3.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
419
4085
2.82
2.20
20.9
12.3
e9/l
272.2
266.5
1.05
413
4003
(40761511) CBC panel - Blood by Automated count
402
3846
1.84
2.17
13.1
8.0
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
9
30
3.04
2.16
1.1
1.2
nmol/l
60.2
47.3
—
9
30
(3013290) Carbon dioxide [Partial pressure] in Blood
10
37
2.74
2.11
4.9
1.8
kpa
5.0
5.0
—
10
37
(3027315) Oxygen [Partial pressure] in Blood
10
37
2.74
2.11
4.9
1.8
kpa
9.6
9.7
—
10
37
(3012516) Albumin [Mass/volume] in Urine
76
558
1.44
2.10
3.9
3.3
mg/l
112.3
189.6
0.21
43
351
(3006653) Thiamine [Moles/volume] in Blood
5
10
5.04
2.07
1.2
1.6
nmol/l
156.4
145.0
—
5
10
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
20
3.54
2.06
1.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
52
355
1.53
2.05
1.4
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
96
739
1.39
2.03
1.6
1.6
mmol/l
1.4
1.2
0.69
82
650
(40761535) Cells panel - Urine sediment
32
194
1.70
2.03
4.9
3.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
10
38
2.67
2.02
1.8
2.6
ug/min
21.6
71.4
—
5
27
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
32
2.85
2.01
1.1
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
52
357
1.52
2.00
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
52
357
1.52
2.00
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
52
357
1.52
2.00
1.4
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
16
77
2.12
1.99
2.1
2.9
g/l
0.4
0.2
—
5
27
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
21
3.37
1.97
1.0
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
87
664
1.39
1.94
1.3
1.3
iu/ml
14.3
25.3
2.47
29
229
(3010813) Leukocytes [#/volume] in Blood
419
4094
2.66
1.93
20.9
12.3
e9/l
7.0
6.6
3.05
412
4004
(3026361) Erythrocytes [#/volume] in Blood
419
4092
2.70
1.92
20.8
12.2
e12/l
4.4
4.5
2.00
410
4009
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
42
278
1.57
1.91
1.6
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
22
3.22
1.88
1.1
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
57
406
1.47
1.85
1.3
1.2
iu/ml
77.3
162.7
1.88
29
169
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
15
74
2.06
1.77
4.8
6.9
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
19
103
1.88
1.74
2.5
2.6
e9/l
62.8
75.3
1.02
11
74
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
30
2.70
1.73
2.0
3.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
13
3.88
1.72
1.0
1.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
29
180
1.66
1.71
11.9
11.5
inr
1.3
1.1
—
6
40
(3025941) Bacteria identified in Stool by Culture
34
220
1.59
1.71
1.1
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
85
661
1.36
1.69
1.2
1.2
u/ml
6.2
13.9
0.79
38
296
(36660697) Celiac disease serology panel - Serum
46
320
1.49
1.69
1.2
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
18
97
1.89
1.68
1.1
1.2
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
8
31
2.61
1.66
1.4
2.1
mmol/l
5.4
6.9
—
8
31
(3003327) Ova and parasites identified in Stool by Light microscopy
23
135
1.74
1.66
1.6
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
47
330
1.48
1.65
4.9
2.8
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
20
113
1.81
1.63
1.3
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
68
513
1.39
1.63
1.3
1.3
titre
1053.3
682.4
—
9
118
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
10
43
2.36
1.61
1.1
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
13
63
2.10
1.61
1.4
1.4
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
8
32
2.53
1.60
1.4
2.1
mmol/l
1.0
1.2
—
8
32
(3052851) Hemolysis interference index of Serum or Plasma
12
57
2.14
1.56
2.8
2.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
18
100
1.84
1.55
1.1
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
28
422
0.64
1.49
2.1
1.8
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
41
290
1.46
1.41
1.5
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
64
491
1.36
1.40
1.9
2.5
ug/g
74.7
86.4
0.38
50
383
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
29
2.44
1.39
1.0
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
21
127
1.69
1.39
2.4
2.5
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
9
41
2.22
1.37
1.7
1.8
ug/l
311.9
228.9
—
9
34
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
23
2.63
1.37
1.0
1.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
17
97
1.78
1.37
1.1
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
41
292
1.45
1.37
1.5
1.4
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
5
17
2.96
1.36
1.2
1.1
mg/l
369.2
333.0
—
5
17
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
50
372
1.39
1.32
2.1
2.6
ng/l
155.7
386.4
0.41
21
192
(44790047)
6
24
2.52
1.31
1.2
1.6
—
—
—
0
0
(44790049)
6
24
2.52
1.31
1.2
1.6
—
—
—
0
0
(44790048)
6
24
2.52
1.31
1.2
1.6
—
—
—
0
0
(44806118)
6
24
2.52
1.31
1.2
1.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
336
3171
1.28
1.30
16.4
9.7
%
13.4
13.4
0.35
329
3111
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
132
1127
1.25
1.30
1.8
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
18
2.80
1.29
2.0
3.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
18
2.80
1.29
1.0
1.2
miu/ml
1208.0
1969.2
—
5
18
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
94
772
1.28
1.28
2.0
1.5
mg/l
1.0
0.7
0.81
70
568
(3021879) Hepatitis B virus core Ab [Presence] in Serum
46
340
1.40
1.26
1.5
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
51
386
1.37
1.22
1.5
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
41
299
1.41
1.22
1.6
1.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
19
2.65
1.22
1.2
2.2
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
5
19
2.65
1.22
1.2
2.2
mmol/l
108.2
105.2
—
5
19
(3041354) Potassium [Moles/volume] in Venous blood
5
19
2.65
1.22
1.2
2.2
mmol/l
3.9
3.9
—
5
19
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
23
149
1.57
1.20
1.3
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
38
2.13
1.19
1.0
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
35
0.00
1.15
0.0
1.7
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
20
2.52
1.15
1.0
1.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
85
699
1.27
1.14
1.5
1.5
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
11
58
1.92
1.13
1.5
1.3
u/ml
69.2
118.1
—
5
16
(3044290) Cell count panel - Cerebral spinal fluid
11
58
1.92
1.13
1.2
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
7
30
2.35
1.13
1.0
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
30
2.35
1.13
1.0
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
30
2.35
1.13
1.0
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
31
2.28
1.11
1.0
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
31
2.28
1.11
1.0
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
31
2.28
1.11
1.0
1.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
21
2.40
1.09
3.0
1.3
pg
33.6
32.0
—
5
21
(3050129) First trimester maternal screen panel - Serum or Plasma
57
449
1.31
1.07
1.5
1.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
7
33
2.14
1.06
2.7
1.9
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
21
138
1.55
1.05
1.3
1.1
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
16
98
1.66
1.04
9.1
1.9
g/l
3.6
3.5
0.05
16
92
(3026493) Urate [Moles/volume] in Serum or Plasma
84
701
1.25
1.01
2.3
2.1
umol/l
4052.4
5019.7
0.09
72
631
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
40
521
0.74
1.00
1.3
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
36
267
1.38
1.00
1.7
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
7
36
1.96
0.97
1.1
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
43
330
1.34
0.97
1.9
1.7
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
12
69
1.76
0.97
1.2
1.3
mg/l
326.3
397.6
1.11
12
63
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
47
367
1.32
0.95
2.5
2.2
e6/l
5.0
4.2
0.17
28
188
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
9
52
1.75
0.93
1.4
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
9
52
1.75
0.93
2.6
3.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
57
459
1.28
0.92
2.0
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
46
360
1.31
0.92
1.1
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
14
86
1.65
0.92
1.5
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
12
71
1.71
0.89
1.1
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
12
72
1.69
0.86
4.0
3.4
—
—
—
0
0
(44813793)
6
31
1.95
0.84
1.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
6
31
1.95
0.84
1.2
1.3
—
—
—
0
0
(3000492) Spirometry study
25
340
0.72
0.84
1.4
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
11
65
1.71
0.83
1.1
1.3
ug/g
274.8
335.2
—
5
31
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
58
1.74
0.80
1.2
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
21
149
1.43
0.77
1.5
1.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
39
307
1.30
0.77
3.6
3.0
%
29.6
33.0
1.20
33
219
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
72
611
1.21
0.76
2.2
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
29
378
0.75
0.75
1.2
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
24
2.10
0.74
1.4
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
25
2.01
0.73
1.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
13
84
1.56
0.72
1.2
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
9
57
1.59
0.71
1.2
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
48
393
1.25
0.71
2.7
2.0
e6/l
0.6
0.8
0.40
29
212
(3004616) Nuclear Ab [Presence] in Serum
7
41
1.72
0.70
1.4
1.3
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
9
58
1.56
0.70
1.4
1.6
—
11.2
—
0
5
(4268621)
7
42
1.68
0.68
2.0
2.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
18
128
1.42
0.66
2.2
2.0
iu/l
5.4
5.5
—
7
57
(3023410) Appearance of Cerebral spinal fluid
5
28
1.79
0.66
1.2
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
78
1.55
0.66
1.4
1.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
118
1060
1.16
0.65
4.0
2.6
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
5
29
1.73
0.64
3.2
3.6
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
8
50
1.61
0.61
1.0
1.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
0
20
0.00
0.60
0.0
2.9
—
51.8
—
0
8
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
27
211
1.30
0.58
6.2
3.7
%
0.8
0.7
—
8
48
(3016244) Insulin [Units/volume] in Serum or Plasma
6
36
1.68
0.57
2.2
4.2
mu/l
24.1
25.8
—
6
36
(3004716) Salmonella sp identified in Stool by Organism specific culture
32
258
1.26
0.55
1.4
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
16
116
1.39
0.55
1.4
2.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
9
61
1.49
0.54
2.7
2.8
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
9
62
1.46
0.53
1.3
1.6
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
39
1.55
0.53
1.0
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
39
1.55
0.53
1.0
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
65
1.39
0.51
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
78
694
1.15
0.50
1.4
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
45
1.56
0.49
1.3
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
135
1248
1.12
0.48
1.4
1.6
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
47
1.50
0.48
1.1
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
41
348
1.20
0.46
1.1
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
27
219
1.25
0.46
2.7
2.0
ml/min/173m2
71.0
83.6
0.73
14
81
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
11
77
1.44
0.46
1.1
1.1
u/ml
2.3
2.8
—
6
45
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
112
1.35
0.45
1.2
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
69
1.46
0.44
1.3
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
9
131
0.68
0.43
1.3
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
25
203
1.25
0.43
6.6
3.7
%
0.0
0.2
—
7
45
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
16
122
1.32
0.43
1.4
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
20
158
1.28
0.42
1.8
1.7
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
24
195
1.24
0.41
5.5
3.5
%
0.4
0.6
—
7
35
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
5
33
1.52
0.41
1.0
1.4
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
16
0.00
0.41
0.0
1.7
—
—
—
0
0
(1002224) Polysomnography panel
19
150
1.28
0.41
1.0
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
24
197
1.23
0.38
6.7
3.7
%
0.0
0.2
—
7
37
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
41
1.47
0.36
1.0
1.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
6
43
1.40
0.35
1.0
1.0
—
—
—
0
0
(4034850)
13
100
1.31
0.34
17.2
5.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
45
1.34
0.34
1.3
1.8
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
29
248
1.18
0.32
1.5
1.4
miu/ml
190.4
235.0
0.29
17
141
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
36
314
1.16
0.32
1.5
1.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
316
3230
0.92
0.31
4.1
3.8
—
—
—
0
0
(4094501)
7
52
1.35
0.31
1.1
1.0
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
27
233
1.17
0.28
1.2
1.2
—
15.4
—
0
11
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
62
1.30
0.28
1.5
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
117
0.76
0.28
1.1
1.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
8
64
1.25
0.27
4.0
3.6
mmol/l
1.0
1.1
—
8
56
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
66
1.22
0.27
1.4
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
66
1.22
0.27
1.3
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
49
447
1.11
0.24
1.2
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
28
246
1.15
0.24
2.4
1.7
e9/l
4.1
4.3
0.21
19
219
(1617658) Protocol used for examination of sentinel lymph nodes
5
39
1.29
0.23
1.2
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
39
353
1.12
0.22
1.6
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
22
191
1.16
0.22
1.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
42
1.19
0.21
6.4
1.9
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
0
11
0.00
0.21
0.0
2.6
—
0.2
—
0
11
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
30
268
1.13
0.21
1.5
1.6
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
12
0.00
0.21
0.0
1.3
—
8.3
—
0
12
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.6
—
2.3
—
0
5
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
5
43
1.16
0.21
1.4
2.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.5
—
10.9
—
0
13
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
24
212
1.14
0.20
3.6
2.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
50
1.20
0.20
1.2
1.0
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
6
53
1.13
0.18
12.8
3.0
nmol/l
1.0
0.9
—
6
46
(3013139) Helicobacter pylori Ag [Presence] in Stool
27
242
1.12
0.18
1.0
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
7
58
1.21
0.18
1.3
1.1
%
131.7
117.7
—
7
52
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
12
101
1.19
0.16
1.2
1.3
—
71.6
—
0
9
(3014051) Protein [Presence] in Urine by Test strip
8
70
1.15
0.16
1.4
1.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
72
1.11
0.16
1.5
1.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
13
111
1.18
0.16
1.3
1.9
g/l
0.2
0.2
0.00
13
104
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
13
112
1.17
0.14
1.5
1.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
32
295
1.09
0.14
1.6
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
13
113
1.16
0.13
1.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
149
1528
0.96
0.12
2.6
2.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
330
3329
0.96
0.10
17.4
10.0
g/l
332.5
332.0
0.39
330
3300
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
47
1.06
0.09
1.0
1.0
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
13
116
1.12
0.09
1.3
1.8
g/l
1.2
1.2
0.05
13
108
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
17
185
0.92
0.08
2.7
2.1
—
—
—
0
0
(4306422)
7
64
1.10
0.08
1.3
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
65
1.08
0.08
1.1
1.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
27
254
1.07
0.08
2.3
2.2
—
16.8
—
0
22
(3009542) Hematocrit [Volume Fraction] of Blood
355
3529
1.04
0.07
13.4
8.7
%
39.0
39.6
0.85
268
2967
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
77
1.04
0.07
1.4
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
77
1.04
0.07
1.0
1.1
—
—
—
0
0
(4010399)
15
163
0.92
0.07
1.4
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
10
91
1.10
0.04
2.5
1.8
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
11
117
0.94
0.01
1.2
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
10
103
0.97
0.00
1.4
1.7
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
10
103
0.97
0.00
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
10
103
0.97
0.00
1.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
11
112
0.98
0.00
3.0
2.2
—
—
—
0
0
(4035726)
24
242
0.99
0.00
1.3
1.4
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
16
159
1.01
0.00
1.3
1.2
ug/l
2.5
3.5
0.60
16
147
(40768804) Tissue Pathology biopsy report
149
1491
1.00
0.00
1.7
1.9
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
49
1.02
0.00
1.0
1.9
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4133840)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
0
5
0.00
0.00
0.0
3.8
—
6.4
—
0
5
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
1.3
—
0
5
(3013293) Extractable nuclear Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
5
0.00
0.00
0.0
6.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
64
0.94
0.00
3.5
3.2
e9/l
4.2
3.8
—
6
64
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
9
0.00
0.00
0.0
2.9
—
46.7
—
0
9
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
66
0.91
0.00
3.8
3.5
%
57.2
56.5
—
6
66
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
9.4
—
0
6
Mortality – FinRegistry
↥Association
Association between endpoint KRA_PSY_PUERPER_EXMORE and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have KRA_PSY_PUERPER_EXMORE.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: KRA_PSY_PUERPER_EXMORE – Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data